Curative and Truepill have announced a partnership to give patients who test positive for COVID-19 at a Curative testing site easy access to telehealth and next-day antiviral treatment options. This partnership will provide Texans access to treatment for Curative patients who test positive for COVID-19.
After taking a COVID-19 molecular or antigen test at a Curative testing site, results are delivered directly to the patient. If they test positive, they can take advantage of Truepill's convenient COVID-19 virtual care platform to access antiviral treatment options quickly and easily.
Patients who test positive within five days of mild to moderate symptom onset will have access to on-demand telehealth consults with US-licensed healthcare professionals. If eligible, an antiviral prescription will be shipped directly to their door or sent to their local pharmacy. By leveraging Truepill's scalable direct-to-patient telehealth platform and nationwide prescription fulfillment and delivery capabilities, Curative ensures all eligible patients have access to the treatment they need.
Curative's COVID-19 testing appointments are available nationwide. Visit curative.com to book a testing appointment and see the full range of Curative's offerings. More information on Truepill and its telehealth, diagnostics, and pharmacy services are available at truepill.com.
Curative Announces Partnership with Truepill for Easy Access to Telehealth Consults and COVID-19 Antiviral Treatments
Original source can be found here.
Alerts Sign-up